MMED
MiniMed Group, Inc. Common Stock NASDAQ$12.11
Mkt Cap $3.4B
52w Low $12.01
1.2% of range
52w High $20.48
50d MA $15.03
200d MA $15.03
P/E (TTM)
-13.6x
EV/EBITDA
48.5x
P/B
1.0x
Debt/Equity
0.0x
ROE
—
P/FCF
-98.0x
RSI (14)
—
ATR (14)
—
Beta
0.00
50d MA
$15.03
200d MA
$15.03
Avg Volume
1.2M
About
MiniMed Group, Inc. engages in the development, manufacturing, and marketing of a wide range of medical devices and solutions for diabetes management. Its offerings include insulin pumps, continuous glucose monitoring systems, infusion sets, software platforms, and related accessories that help patients and healthcare providers effectively monitor and control blood glucose levels. The company was …
Recent Earnings
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | 1M% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 17, 2026 | AMC | 0.17 | 0.20 | +17.5% | 14.44 | -0.6% | -4.4% | -8.6% | -8.7% | -5.6% | -8.6% | — | — |
Recent Filings
8-K · 7.01
! Medium
MiniMed Group, Inc. -- 8-K 7.01: Regulation FD Disclosure
Medtronic disclosed an unauthorized third-party breach of its IT systems; the company activated incident response protocols and engaged external cybersecurity experts to investigate and remediate the security breach.
Apr 27
8-K · 5.02
!!! Very High
Unknown — 8-K 5.02: Executive Change
I cannot provide a meaningful analysis of this filing because the summary provided is incomplete and contains only procedural language referencing exhibits rather than details about the actual executive change, compensation, or departure rationale.
Mar 27
8-K · 7.01
! Medium
Unknown — 8-K 7.01: Regulation FD Disclosure
MindMed's incomplete FD disclosure regarding future period results raises concerns about management's confidence in guidance and potential operational challenges, warranting cautious investor attention.
Mar 25
8-K · 7.01
! Medium
Unknown — 8-K 7.01: Regulation FD Disclosure
Medtronic will face $0.04 per-share dilution in Q4 FY2026 from its MiniMed IPO, creating near-term EPS headwinds that investors should factor into earnings estimates.
Mar 24
8-K · 5.02
!!! Very High
MiniMed Group, Inc. -- 8-K 5.02: Executive Change
Brian Sandstrom's resignation as director of MiniMed Group signals potential leadership transitions that investors should monitor for impact on board oversight and strategic direction.
Mar 9
Data updated apr 26, 2026 12:40pm
· Source: massive.com